- Rentschler Biopharma to provide cGMP manufacturing
services for mRNA-based vaccine candidate, developed by BioNTech and
Pfizer against SARS-CoV-2
- Commercial production will be conducted in Laupheim,
Germany
- Rentschler Biopharma’s innovative and highly flexible
business model enables fast, high-quality, large-scale manufacturing for
commercial supply as well as small batch production for clinical trials
for other BioNTech RNA product candidates
LAUPHEIM, GERMANY and MILFORD, MA, USA – EQS Newswire
– 8 October 2020 – Rentschler
Biopharma SE, a leading global contract development and manufacturing
organization (CDMO) for biopharmaceuticals, today announced an agreement to
serve as CDMO partner for BioNTech. As an initial project, Rentschler Biopharma
will be responsible for key aspects of cGMP (current good
manufacturing practice) drug substance manufacturing of BNT162b2, the
mRNA-based vaccine against SARS-CoV-2 that is being developed by Pfizer and
BioNTech, and is currently in a global Phase 3 clinical trial.
Under the agreement, Rentschler Biopharma will
be responsible for downstream processing to provide highly
purified drug substance. Process and product-related impurities will be
effectively removed from the intermediate pool, which has been previously
derived from mRNA synthesis. This is an important step in ensuring the safety
and tolerability of a vaccine for use in humans, while at the same time
maximizing the amount of mRNA harvested from the initial production process.
Rentschler Biopharma will produce purified drug substance at its headquarters
in Laupheim, Germany.
Dr. Frank Mathias, CEO of Rentschler Biopharma,
said: “We are honored to contribute to BioNTech’s ‘Project Lightspeed’ and
their work in developing this highly innovative mRNA vaccine. To tackle the
COVID-19 pandemic, it is critical to bring high-quality, safe and effective
vaccines to the public quickly and on a large scale. At Rentschler Biopharma,
we feel it is important to do our part in combatting this virus. As a cGMP
service provider with more than 40 years of proven manufacturing expertise, we
are well suited to work with BioNTech to make their ground-breaking science a
medical reality and will work tirelessly to this end.”
BioNTech and Rentschler Biopharma will use an
innovative business model that is well suited for novel, urgently needed
technologies and allows maximum flexibility to address BioNTech’s development
and manufacturing requirements. In addition to large-scale production services
for the COVID-19 vaccine, the agreement also provides for small-batch
manufacturing of BioNTech’s other RNA programs for use in clinical trials.
Federico Pollano, SVP Global Business
Development of Rentschler Biopharma, added: “We are excited to
have the opportunity to work with BioNTech on this urgent project, as well as
over the long term. A critical success factor in all the projects we take on at
Rentschler Biopharma is close collaboration with our clients. Working in
partnership with BioNTech, we determined that the best way to address their
COVID-19 vaccine drug substance manufacturing needs was to establish a
dedicated mRNA production suite for them in our Laupheim facility. This
approach ensures capacity, staff and equipment are ready when needed without
interruption of other ongoing projects at our site. It is also an approach that
is quickly and easily scalable to meet future demands.”
About Rentschler Biopharma SE
Rentschler Biopharma is a leading contract
development and manufacturing organization (CDMO), focused exclusively on
client projects. From its headquarters in Laupheim, Germany and its site in
Milford, MA, USA, Rentschler Biopharma offers process development and
manufacturing of biopharmaceuticals as well as related consulting activities,
including project management and regulatory support. Rentschler Biopharma’s
high quality is proven by its long-standing experience and excellence as a
solution partner for its clients. A high-level quality management system, a
well-established operational excellence philosophy and advanced technologies
ensure product quality and productivity at each development and manufacturing
step. In order to offer best-in-class formulation development along the
biopharmaceutical value chain, the company has entered into a strategic alliance
with Leukocare AG. Rentschler Biopharma is a family-owned company with about
1,000 employees. For further information, please visit www.rentschler-biopharma.com. Follow Rentschler
Biopharma on LinkedIn and Facebook.
Services
Stakeholder mapping, analysis, engagement and communication needs to be detailed to avoid business losses or even worse, a crisis. How can you do this effectively to prevent failure? ...
Data-driven business decisions have never been as crucial, especially in this era. MGBF leverages off, technology, experience and market presence to aid businesses in making accurate decisions. ...
MGBF provides comprehensive strategic advice and results-focused solutions to solve clients' problems in business-government relations so they can focus on their core business. ...
A critical business challenge is meeting the right decision-makers and potential buyers through the best channel and platform. How will you improve your business competency? ...
Upcoming Events
In this episode of 'A Working Lunch with Nordin', MGBF's Nordin Abdullah and regional commentator Eddin Khoo will discuss the biggest threats and opportunities for businesses as we look to manage change in the South China Sea.
This MGBF Roundtable will feature thought leaders form Japan, Australia, Singapore and Malaysia dealing with the critical issues of manipulation of public listed companies and government and their financial impacts.
A series of networking sessions with various business associations and trade organisations exploring high-value opportunities for business leaders and entrepreneurs looking to build the relationships that matter.
This integrated event will include a forum, dedicated business matching, site visits, a gala dinner and a round of golf. Aptly themed, the focus will be on regional food security issues and trends in the context of the supply chain, agriculture technology and trade regulations and policies.
MGBF In The News
Planet QEOS and China Machinery Engineering Corporation (CMEC) are interested in investing RM10 billion to co-develop advanced Megawatt peak (MWp) agrovoltaic in Baram, to further boost Sarawak’s green energy initiative and food security. Sarawak Premier Datuk Patinggi Tan Sri Abang Johari Tun Openg was briefed on Friday by both the […]
Last week SPM results came out, 373,974 aspirants who have been waiting patiently over the last few months would now know their fate. Some 10,109 have received all A’s, the golden standard of academic success and the ticket to those looking to study the “more advanced” subjects in university. Proudly, […]
The classic knee-jerk reaction is to say, fire the coach, change the leadership of associations, and reduce the funding till they start performing better. This kind of negative reinforcement may work for kindergarten children, but we are dealing with high-performance adults – individuals much further along in their psychological and […]
Since its earliest tea plantations in 1929, Cameron Highlands has grown to become a key player in the agricultural landscape of Malaysia, producing 40 per cent of all vegetables grown. Despite Malaysia shifting its economic focus away from agriculture, the industry remains imperative for food security and the livelihoods of […]
Although at first glance the travel industry and the agricultural sector appear to have nothing in common, they actually share more than meets the eye. The economic benefits of tourism to the agricultural sector can be multiplied several times over. “Tourism brings the end consumers closer to the source, which […]
The Malaysia Global Business Forum (MGBF) recently held a high-level roundtable themed ‘Designing the Future of the Digital Economy’, attended by industry leaders and business associations. The guest of honour was Yang Berhormat Syerleena Abdul Rashid, the Member of Parliament (MP) for Bukit Bendera in Penang. The MP’s Special Session […]
The Malaysia Global Business Forum (MGBF) will be hosting a roundtable on ‘Designing the Future of the Digital Economy’ on 23 February 2023. It is the culmination of the first three MGBF Exclusive Roundtable Series titled ‘The Evolving Threat Matrix in the Digital Economy’ held throughout 2022. According to the […]
The Founding Chairman of the Malaysia Global Business Forum (MGBF), Nordin Abdullah, today spoke on Bernama TV’s leading English talk show, The Brief, hosted by Jessy Chahal, on the topic of a stable political reality and what that means for the Malaysian economy. Nordin said, “The first thing that it […]
More than 1,100 years ago, Muhammad ibn Musa al-Khwarizmi was developing the mathematical formulas that we know today as algorithms which now have become so intertwined with the business fortunes of global media giants and the very fabric of geopolitics. A series of recent high level international reports have revealed […]
KSK Land has been recognised by the Malaysia Global Business Forum (MGBF) for its role in attracting high net-worth individuals to Malaysia post-pandemic. The first challenge in investor attraction is “selling” the country. In the context of Asia, Malaysia is competing with some very established investment destinations. The second […]
Malaysia, in particular Kuala Lumpur, continues to position itself as a regional centre to do business, educate a family and enjoy a global lifestyle. One company, KSK Land, has taken the lead in positioning itself and the city of Kuala Lumpur as a property investment destination for the global citizen […]
The upcoming budget represents an opportunity to build resilience in the critical sectors that will form the backbone of the country’s future-facing economic ambitions. This however needs to be achieved in the context of managing the community sectors most impacted by COVID-19 over the past two years. The Keluarga Malaysia (Malaysian Family) […]
Malaysia Global Business Forum (MGBF) has moved to support the creative economy as the overall economy moves into a recovery phase following the COVID19 pandemic. As a step in the direction of normalcy, the MGBF has agreed to host the art exhibition “I Know You’re Somewhere So Far” by one […]
Congratulations to Datuk Seri Ismail Sabri Yaakob for taking up the mantle of the ninth prime minister of Malaysia. There is nothing normal about the situation; it could not have been scripted but it has kept the spectrum of media, mainstream and social, gripped. The first order of business for […]
In a stirring speech to the nation, President Joseph R. Biden, Jr. stamped his brand of leadership on the presidency, in his first act as the 46th president of the United State of America, it signaled several shifts. Perhaps the weather was foreboding with snow falling before the ceremony that […]
KUALA LUMPUR, 6 July 2022 – As the global economy continues to deal with unprecedented levels of disruption caused by the pandemic and the conflict between Russia and Ukraine, the convergence of energy security and food security issues has become a front-of-mind issue faced by policy makers and consumers alike. […]
KUALA LUMPUR, 23 June 2022 — Malaysia Global Business Forum (MGBF) ties up with scoutAsia to ensure that businesses are equipped with deeper regional insights. The past two years has seen a massive shift in the way businesses are conducted with digitisation, digitalisation and automation continuously being adopted to improve […]
KUALA LUMPUR, 25 May 2022 – The Malaysia Global Business Forum (MGBF)’s exclusive roundtable on ‘Security Concerns in Critical Value Chains’ was held in a hybrid setting yesterday at the Eastin Hotel Kuala Lumpur. The guest of honour was Yang Berbahagia Tan Sri Dato’ Seri Rafidah Aziz, former minister of […]
We live in the age of crisis. At the heart of any crisis is the threat of rapid change. Change too deep or too wide that the current coping mechanisms for an individual, corporation or government are unable to remain resilient. An unwelcome paradigm shift, like the proverbial spider, that […]